Team

Staff Profiles

Kimberly R. Metzler, Ph.D.

Scientific Program Manager

Kimberly (Kim) is the Scientific Program Manager at the Allen Institute for Cell Science. Kim obtained her Ph.D. in Genetics & Development from University of Texas Southwestern Graduate School of Biomedical Sciences.  During her Ph.D., she focused on understanding the molecular events that instructed cardiac cell fate decisions. In 2008, Kim continued her postdoctoral fellowship with Deepak Srivastava at the Gladstone Institutes and University of California San Francisco. While there, she focused on cardiac disease modeling using human induced-pluripotent stem cells (iPS) derived from patients with inherited disease. In 2012, Kim became a co-investigator with Gladstone Investigator, Israel Charo, on an NIH Research grant focused on monocyte recruitment during atherosclerotic plaque formation. 

In 2014, Kim joined the former start-up, Cellular Research, Inc. She helped develop a massively-parallel single-cell RNA-sequencing platform for commercialization. While there, she gained invaluable project management skills and helped to build a cross-disciplinary team. By 2015, Cellular Research, Inc. was acquired by Becton Dickinson (BD) Genomics. As a Senior Scientist at BD, Kim was involved in the product development of BD RhapsodyTM, a revolutionary single-cell platform to enable high-throughput single-cell sequencing (NGS). In late 2016, Kim returned to Gladstone Institutes as their Program Manager for BioFulcrum, where she managed a portfolio of entrepreneurial research projects. She was involved in maintaining team alignment towards achieving research milestones, including the generation of gene-edited human iPS cell lines and transcriptomic datasets from human iPS-derived cardiomyopathies. 

​Kim joined the Cell Science team in July of 2018 to provide project management oversight of the research science based on the priorities and mission of the Institute. She has always had a passion for understanding the fundamental events involved in cell fate determination and differentiation that leads to organogenesis and goes awry in disease. Therefore, Kim is excited to align her scientific passion with her program management experience to advance the mission of the Allen Institute for Cell Science.

Expertise

  • Project Management

  • Genomics

  • Stem Cell Biology

  • Cardiac Development

  • Disease Modeling

Expertise

  • Project Management

  • Genomics

  • Stem Cell Biology

  • Cardiac Development

  • Disease Modeling

Selected Publications

Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier

Science
February 20, 2018

Gifford CA, Ranade SS, Samarakoon R, Salunga HT, Soysa TY, Huang Y, Zhou P, Elfenbein A,  Wyman SK, Bui YK, Cordes Metzler KR, Ursell P, Ivey KN, Srivastava D